299 related articles for article (PubMed ID: 25712684)
1. The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy.
Zsiros E; Duttagupta P; Dangaj D; Li H; Frank R; Garrabrant T; Hagemann IS; Levine BL; June CH; Zhang L; Wang E; Marincola FM; Bedognetti D; Powell DJ; Tanyi J; Feldman MD; Kandalaft LE; Coukos G
Clin Cancer Res; 2015 Jun; 21(12):2840-50. PubMed ID: 25712684
[TBL] [Abstract][Full Text] [Related]
2. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
[TBL] [Abstract][Full Text] [Related]
3. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapy.
Zsiros E; Dangaj D; June CH; Kandalaft LE; Coukos G
Oncoimmunology; 2016 May; 5(5):e1062210. PubMed ID: 27467909
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
6. Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy.
Vavrova K; Vrabcova P; Filipp D; Bartunkova J; Horvath R
Med Oncol; 2016 Dec; 33(12):136. PubMed ID: 27812850
[TBL] [Abstract][Full Text] [Related]
7. Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro.
Li G; Zeng Y; Chen X; Larmonier N; Sepassi M; Graner MW; Andreansky S; Brewer MA; Katsanis E
Clin Exp Immunol; 2007 Apr; 148(1):136-45. PubMed ID: 17349014
[TBL] [Abstract][Full Text] [Related]
8. A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.
Sarivalasis A; Boudousquié C; Balint K; Stevenson BJ; Gannon PO; Iancu EM; Rossier L; Martin Lluesma S; Mathevet P; Sempoux C; Coukos G; Dafni U; Harari A; Bassani-Sternberg M; Kandalaft LE
J Transl Med; 2019 Nov; 17(1):391. PubMed ID: 31771601
[TBL] [Abstract][Full Text] [Related]
9. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
Wong CK; Li PW; Lam CW
Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653
[TBL] [Abstract][Full Text] [Related]
10. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites.
Milliken D; Scotton C; Raju S; Balkwill F; Wilson J
Clin Cancer Res; 2002 Apr; 8(4):1108-14. PubMed ID: 11948121
[TBL] [Abstract][Full Text] [Related]
11. Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
Rapoport AP; Aqui NA; Stadtmauer EA; Vogl DT; Xu YY; Kalos M; Cai L; Fang HB; Weiss BM; Badros A; Yanovich S; Akpek G; Tsao P; Cross A; Mann D; Philip S; Kerr N; Brennan A; Zheng Z; Ruehle K; Milliron T; Strome SE; Salazar AM; Levine BL; June CH
Clin Cancer Res; 2014 Mar; 20(5):1355-65. PubMed ID: 24520093
[TBL] [Abstract][Full Text] [Related]
12. Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T cells.
Juel HB; Faber C; Udsen MS; Folkersen L; Nissen MH
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8472-80. PubMed ID: 23150618
[TBL] [Abstract][Full Text] [Related]
13. Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28.
Rosenblatt J; Wu Z; Vasir B; Zarwan C; Stone R; Mills H; Friedman T; Konstantinopoulos PA; Spentzos D; Ghebremichael M; Stevenson K; Neuberg D; Levine JD; Joyce R; Tzachanis D; Boussiotis V; Kufe D; Avigan D
J Immunother; 2010; 33(2):155-66. PubMed ID: 20145548
[TBL] [Abstract][Full Text] [Related]
14. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
15. Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion.
Brimnes MK; Gang AO; Donia M; Thor Straten P; Svane IM; Hadrup SR
Cancer Immunol Immunother; 2012 Aug; 61(8):1221-31. PubMed ID: 22237888
[TBL] [Abstract][Full Text] [Related]
16. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
17. Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.
van der Voort R; Volman TJ; Verweij V; Linssen PC; Maas F; Hebeda KM; Dolstra H
Biol Blood Marrow Transplant; 2013 Mar; 19(3):378-86. PubMed ID: 23266741
[TBL] [Abstract][Full Text] [Related]
18. Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets.
Kang S; Xie J; Ma S; Liao W; Zhang J; Luo R
Immunobiology; 2010; 215(2):153-62. PubMed ID: 19450895
[TBL] [Abstract][Full Text] [Related]
19. The homeodomain transcription factor MEIS1 triggers chemokine expression and is involved in CD8+ T-lymphocyte infiltration in early stage ovarian cancer.
Karapetsas A; Tokamani M; Evangelou C; Sandaltzopoulos R
Mol Carcinog; 2018 Sep; 57(9):1251-1263. PubMed ID: 29802738
[TBL] [Abstract][Full Text] [Related]
20. Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression.
Nguyen N; de Esch C; Cameron B; Kumar RK; Zekry A; Lloyd AR
J Gastroenterol Hepatol; 2014 Apr; 29(4):860-9. PubMed ID: 24236853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
